Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Recruiting · NCT07470151 · Registry updated 2026-03-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Skin and Connective Tissue Diseases, autoimmune disease, autoimmune disorder of the nervous system, connective tissue disorder, diffuse scleroderma, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome, scleroderma, skin disorder, systemic lupus erythematosus, systemic sclerosis | Recruiting | Not applicable | 2026-03-13 | NCT07470151 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Everest Medicines (China) Co.,Ltd. | 4 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Union Hospital Tongji Medical College Huazhong University of Science and Technology | Wuhan | China | 30 |